Unit IV, week 2 Flashcards
General Anesthesia is a ___________ depression with progressive loss of function from ________ to ____________ levels within the CNS
DESCENDING depression: progressive loss of function from HIGHER (cognition, consciousness) to LOWER (respiratory control) levels within the CNS
Stages of general anesthesia (1-4)
Stage I =analgesia
Stage II = excitement, delirium
Stage III = surgical anesthesia
Stage IV = medullary paralysis
-Respiratory failure, vasomotor collapse and resulting circulatory failure lead to death within minutes
Time course of anesthesia (3)
1) Induction
2) Maintenance
3) Recovery
Induction
time between initiation of administration and attainment of surgical anesthesia (until stage III reached)
Maintenance
time during which surgical anesthesia is in effect (surgery)
Recovery
time following termination of administration, complete recovery of patient from anesthesia
Inhaled anesthetics enter _____________ in various membrane proteins (such as what?) –> what effects?
Is this specific binding?
hydrophobic pockets
such as GABA-A receptors
→ overall CNS depression
**Hydrophobic protein pockets within which volatile anesthetics bind are NOT specific binding sites
Rate an effective concentration of anesthetic is reached in brain depends on 5 factors:
1) Concentration of anesthetic in inspired air
2) Alveolar ventilation rate (Respiratory depression can prolong recovery time)
3) Pulmonary blood flow (cardiac output)
4) Blood:gas partition coefficient
5) Potency (oil:gas partition coefficient)
Uptake by blood from alveoli determined by…
how is rate of approach to stage III related to these two factors?
solubility of anesthetic in blood and cardiac output
rate of approach to stage III is INVERSELY PROPROTIONAL to pulmonary blood flow and solubility of anesthetic in blood
Solubility of General Anesthetic
How does solubility of GA in blood effect approach to equilibrium?
rate of rise in partial pressure ratio is faster for gas with low solubility
Highly soluble GA (halothane)→ slower approach to equilibrium because a larger amount must be dissolved in blood
Low-solubility GA (nitrous oxide) exhibits more rapid increase in partial pressure in blood
Faster pulmonary blood flow effects anesthetic uptake how?
Faster pulmonary blood flow → less time for anesthetic to diffuse into blood
Uptake from arterial blood to body tissues depends on (3)
1) anesthetic gas solubility in body tissues
2) tissue blood flow (Higher tissue blood flow = faster delivery)
3) partial pressure of anesthetic in blood/tissues
Tissue distribution of general anesthetics (3)
1) Vessel-rich groups: highly vascularized tissues (brain, heart, kidney, liver, endocrine glands) → high uptake
2) Muscle groups: muscle and skin → slower uptake, 2-4 hours
3) Fat group: very slow uptake due to high ability to dissolve anesthetic
Equally soluble in blood and lean tissues but more soluble in fatty tissue = large reservoir for anesthetic
Oil:gas partition coefficient vs. Blood:gas partition coefficient
Oil:gas partition coefficient = anesthetic potency
-Potency = 1/MAC (minimum alveolar concentration)
Blood:gas partition coefficient = anesthetic uptake and elimination kinetics
Metabolism and excretion of volatile anesthetics
Clearance of inhaled anesthetics primarily by lungs
Metabolism in liver of volatile anesthetics is not important in terminating anesthetic action BUT is important for adverse drug reactions and interactions
Xenon
not used clinically, equivalent potency to Nitrous oxide
Nitrous oxide
- potency?
- use?
- onset?
- contraindications (2)
low potency anesthetic, cannot reach surgical dose
Adjunctive agent due to analgesic and anxiolytic properties
Rapid onset
Contraindications: respiratory obstruction (COPD), pregnancy
Diethyl ether
no longer used
Flammable and explosive
Produces excessive respiratory tract excretions → choking patient
Good analgesic
Chloroform
no longer in common use
Can cause cardiac arrhythmias and hepatotoxicity
Halothane
was most widely used inhalational anesthetic until recently
Highly potent
Induction and recovery not prolonged (low blood:gas coefficient)
non explosive
Halothane negatives (4)
1) Not a good analgesic
2) Can easily produce respiratory and cardiovascular failure (arrhythmias)
3) Hepatotoxic (increased risk with repeated exposure)
4) Can trigger malignant hyperthermia
Malignant hyperthermia
Muscle rigidity, fever
TX = dantrolene (muscle relaxant), blocks Ca2+ release via ryanodine receptor
Can be triggered by halothane
Enflurane
-uses? (4)
negatives? (1)
- Excellent analgesic
- Fast induction and recovery
- Good muscle relaxant
- Less CV effects, less hepatotoxicity
Negatives: Can trigger seizures during induction/recovery
Isoflurane
most widely used inhalational anesthetic
- More potent than enflurane
- Minimal hepatotoxicity or renal toxicity
- No seizure triggering
- Rapid and smooth induction and recovery
- Minimal CV depression
- Good muscle relaxant
Negative: has pungent odor → can cause coughing
Desflurane
- Low blood and fatty tissue solubility → faster recovery
- Pungent odor
- Not hepatotoxic
Contraindicated for malignant HTN patients
Sevoflurane
High potency, low blood:gas coefficient → rapid onset and recovery
Pleasant odor → can be used for induction
Chemically unstable → toxic to kidneys
Thiopental
- mechanism?
- onset?
- use?
ultra-short acting barbiturate
Used for induction of general anesthesia
Rapid onset of action - LOC within 15-20 seconds, reawaken in 3-5 minutes
Propofol
- mechanism?
- use?
- 2 benefits?
potentiates GABA-A receptor
Rapid onset induction anesthetic, fast recovery
Less nausea post-op
No involuntary movements
Etomidate
- mechanism?
- use?
- benefit?
- onset?
- drawback?
potentiates GABA-A receptor
-Used for induction of general anesthesia
Larger safety margin - minimal depression of CV and respiratory function
LOC in seconds, recovery in 3 min
Can cause involuntary patient movements during induction
Ketamine
glutamate receptor antagonist, no action on GABA-A receptor
Catatonia, amnesia, analgesia
Potent bronchodilator
d-Tubocurarine
neuromuscular blocking agent (competitive ACh antagonist)
Relaxes skeletal muscle
Ondansetron
antiemetic
Postop nausea and vomiting
Glycopyrrolate
anticholinergic, given to combat HTN and bradycardia
Main mechanism of general anesthetics
Depress neuronal excitability in CNS via potentiation of GABA-A receptor activity
→ potentiate GABAergic IPSPs in CNS
→ greater inhibition of CNS and depression of neuronal excitability
Main brain regions involved in general anesthesia (3)
Hypothalamic nuclei involved in sleep
Reticular formation of brainstem → control of pain, alertness, sleep
Hippocampus → amnesia of post-op patients
Ideal characteristics of general anesthetics
rapid and smooth onset of action, rapid recovery from anesthesia upon termination of drug administration, and drug has wide margin for safe use
No drug has all these → use combination of drugs
**Specific drug combinations designed to take advantage of desirable properties of individual drugs while attenuating undesirable side effects
Identification of attentional dysfunction
Gold standard = good history and exam - screens supportive, but not sufficient
NOT a learning disorder, intellectual disability, or oppositional behavior
Types of ADHD (3)
1) Inattentive type
2) Hyperactive type
3) Combined type
Inattentive type
Frequently undiagnosed, more common in girls
Fails to give close attention to details, difficulty sustaining attention
Doesn’t appear to listen, struggles to follow instructions
Difficulty with organization, avoids tasks with lots of thinking
Loses things, easily distracted, forgetful
Hyperactive type
Diagnosed earlier (bothersome to others), frequently confused with oppositionality
Fidgets, squirms, difficulty remaining seated
Difficulty engaging in activities quietly, talks excessively
Blurts out answers before questions have been completed, interrupts others, difficulty waiting or taking turns
Combined type ADHD
meets criteria for both (6 symptoms from each category)
Functional impact of ADHD
Less likely to graduate from high school, get a higher education, and work in a professional environment.
More likely to use drugs/alcohol/tobacco and be incarcerated
Common comorbidities with ADHD
substance abuse, anxiety disorders, depression, learning disorders, oppositional behavior
Why is comorbidity so high with ADHD (5)
Underlying genetic vulnerability
Developmental changes
Psychological effects of having ADHD
Living with others who are irritated by the ADHD
Self-treating the problem
Treatment of ADHD (4)
1) Stimulants
2) Atomoxetine
3) Bupropion (Wellbutrin)
4) Alpha agnoists (guanfacine, clonidine)
- Mostly affect hyperactive symptoms
Stimulants used for treatment of ADHD (2 types)
standard of care
Amphetamines: Adderall, Vyvanse
Methylphenidates: Ritalin, Concerta
ADHD Long term
lifelong disorder that frequently requires chronic treatment
65% continue to have ADHD symptoms into adulthood
Hyperactivity tends to decrease with time
Inattentive symptoms, restlessness and impulsivity remain
Long term treatment of ADHD
Focus on quality of life, treatment can decrease burden on partner
May still need stimulants as adults
Epilepsy
tendency for recurrent seizures because of an underlying brain abnormality
disorder of recurrent spontaneous seizures
Generalized or partial
post ictal and during seizure
Postictal period: negative symptoms, loss of function in areas of brain involved
-Due to neuronal exhaustion or inhibitory inputs to that area
During seizure → positive symptoms
Signs of epileptic seizures
paroxysmal change in behavior or movement, or an alteration of consciousness
Focal (partial) seizures vs. Generalized seizures
Focal: begin in one area of cortex, remains localized or spreads
Generalized seizures: begins because cortex as a whole is hyper-irritable
Focal (partial) seizure with consciousness preserved
SIMPLE seizure
not effecting awareness or memory
Focal (partial) seizure with loss or impairment of consciousness
COMPLEX seizure
Partial onset followed by impairment of consciousness
affecting awareness or memory of events before, during, and immediately after the seizure and affecting behavior
Focal seizures can evolve (spread like a brush fire to “bigger seizure” including convulsive seizure)
Absence seizures
Generalized seizure
Involve widespread areas of cortex, but not all layers of neurons
Period of AMS unaccompanied by major motor manifestations
Partial complex seizures
followed by postictal state (most absence seizures are not)
Period of AMS unaccompanied by major motor manifestation
Often hard to distinguish from absence seizures
Seizures
episodic events which are unexpected and sudden resulting from abnormal and excessive activity of neurons
Involves electrical functions of brain
Intractable epilepsies
do not respond to trial of at least 3 anticonvulsants
30% of new onset seizure patients may develop intractable epilepsy
Febrile Seizures
Event in infancy/childhood occurring between 3 mos and 5 yrs, associated with fever but without evidence of intracranial infection or defined cause
Most common childhood seizure
No proof of occurrence with rise in fever
Usually within first 24hrs of illness
Simple vs. Complex febrile seizure
Simple: generalized, last 10-15 minutes, do not recur within 24 hrs
Complex: focal in nature, at onset, or during, longer than 10-15 min, recur in less than 24 hours
20-30% of febrile seizures are complex
What is the likelihood of future seizures after a febrile seizure?
25-40% will have recurrent febrile seizure
Future impact of febrile seizures on sleep, cognition, and risk of epilepsy
Cognition: almost all will have normal cognition, prolonged/complex than may have increased risk of cognitive problems
Sleep: tendency to have sleep problems, nightmares
Increased risk of epilepsy with complex seizure, neurological abnormality, or family history of afebrile seizures
Mechanisms of Seizure Pathophysiology (2 main ways neuronal membrane is made unstable)
unstable neuronal membrane (focal epileptogenesis → initiation)
1) Paroxysmal discharges can recruit and synchronize a large population of cortical neurons or neurons in thalamic region
2) Enhancement of excitatory neurotransmitters (primarily glutamate) or deficiency of inhibitory neurotransmitters (primarily GABA) can promote spread or propagation of abnormal activity as can metabolic causes.
Common causes of seizure: primary and secondary
Primary: hereditary or idiopathic causes
Secondary: mechanical (trauma, brain tumor), metabolic (hypoxia, hypoglycemia, hypocalcemia, alkalosis), withdrawal of CNS depressant drugs, toxins
Consequence of seizure
seizure activity → increased O2 demand of CNS → insufficient O2 supply → ischemia → brain damage (neuronal destruction)
Seizures beget seizures
3 drugs used to treat Grand mal (tonic clonic) seizures
valproate, lamotrigine, levetiracetam
Mechanism of grand mal seizure (4)
1) Loss of GABA inhibitory tone
2) Propagation due to decreased GABA tone over large area
3) Increased response to glutamate
4) Na+ channel excitation
Features of a grand mal (tonic clonic) seizure
loss of postural control, LOC, tonic phase (rigid extension of trunk and limbs), clonic phase (rhythmic contraction of arms and legs)
2 drugs used to treat a petit mal (absence) seizure
Ethosuximide, Valproate
Mechanism of petit mal (absence) seizure
inappropriate activation of low-threshold T-type Ca2+ channels
Features of petit mal (absence) seizure
normal muscle tone, impaired consciousness with staring spells (with/without eye blinks), function normal after seizure
Mechanism of partial seizures
involves initiation (Rather than propagation) → more difficult to treat
3 drugs used to treat partial seizures
carbamazepine, lamotrigine, levetiracetam
Treatment of status epilepticus (inpatient vs. outpatient)
BDZS → diazepam, lorazepam, midazolam
Inpatient → Fosphenytoin, Levetiracetam
Treatment of Atonic Myoclonic seizures (3 drugs)
Valproate, Levetiracetam, Lamotrigine
*same drugs that treat tonic clonic grand mal seizure!
Two goals of anticonvulsants
elevate seizure threshold (Stabilize membrane) and limit propagation (reduce synaptic transmission or nerve conduction)